Ritalin-SR (Methylphenidate Hydrochloride Sustained Release) - Summary

RITALIN-SR SUMMARY

Ritalin hydrochloride, methylphenidate hydrochloride USP, is a mild central nervous system (CNS) stimulant, available as tablets of 5, 10, and 20 mg for oral administration; Ritalin-SR is available as sustained-release tablets of 20 mg for oral administration.

Ritalin hydrochloride is indicated for the following: Attention Deficit Disorders, Narcolepsy.

See all Ritalin-SR indications & dosage >>

RITALIN-SR NEWS HIGHLIGHTS

Media Articles Related to Ritalin-SR (Methylphenidate)

US FDA Approves 30-Minute Onset Of Action For Focalin(R) XR, Bringing Potential Benefits To ADHD Patients During Early Morning Period
Source: ADHD News From Medical News Today [2008.11.13]

more >>

Published Studies Related to Ritalin-SR (Methylphenidate)

Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study. [2008.08]

[Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children] [2008.08]

Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. [2008.06]

Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. [2008.06]

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. [2008.06]

more >>

Clinical Trials Related to Ritalin-SR (Methylphenidate)

A Comparative Effectiveness Study Evaluating OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children [Completed]

An Effectiveness and Safety Study Evaluating OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder [Completed]

A Double-Blind Randomized, Placebo-Controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-Acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults [Completed]

A Multicenter Study Comparing the Efficacy and Safety of OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder [Completed]

Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate [Completed]

more >>